LKB1 modulates lung cancer differentiation and metastasis
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Germline mutation in serine/threonine kinase 11 (STK11, also called LKB1) results in Peutz-Jeghers syndrome, characterized by intestinal hamartomas and increased incidence of epithelial cancers. Although uncommon in most sporadic cancers, inactivating somatic mutations of LKB1 have been reported in primary human lung adenocarcinomas and derivative cell lines. Here we used a somatically activatable mutant Kras-driven model of mouse lung cancer to compare the role of Lkb1 to other tumour suppressors in lung cancer. Although Kras mutation cooperated with loss of p53 or Ink4a/Arf (also known as Cdkn2a) in this system, the strongest cooperation was seen with homozygous inactivation of Lkb1. Lkb1-deficient tumours demonstrated shorter latency, an expanded histological spectrum (adeno-, squamous and large-cell carcinoma) and more frequent metastasis compared to tumours lacking p53 or Ink4a/Arf. Pulmonary tumorigenesis was also accelerated by hemizygous inactivation of Lkb1. Consistent with these findings, inactivation of LKB1 was found in 34% and 19% of 144 analysed human lung adenocarcinomas and squamous cell carcinomas, respectively. Expression profiling in human lung cancer cell lines and mouse lung tumours identified a variety of metastasis-promoting genes, such as NEDD9, VEGFC and CD24, as targets of LKB1 repression in lung cancer. These studies establish LKB1 as a critical barrier to pulmonary tumorigenesis, controlling initiation, differentiation and metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beyond its role regulating metabolism via AMPK, LKB1 loss promotes tumorigenesis by reprogramming epigenetic states, facilitating lineage plasticity and promoting metastasis22,67–70.”
From LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers (2025) · cites this paper as [22]
In the citing paper
“Somatic deletion of Lkb1 is insufficient for initiation of lung carcinogenesis in mice as a singular event but dramatically accelerates KrasG12D-driven carcinogenesis and fosters early metastatic dissemination84.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [84]
In the citing paper
“In addition, loss of Lkb1 results in epigenetic reprogramming and an expanded tumor histological repertoire, with high incidence of squamous or adenosquamous carcinomas, in agreement with data supporting enrichment of LKB1 mutations in human adenosquamous NSCLC84–86.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [84]
In the citing paper
“Loss of p53 or expression of either dominant negative or dominant gain-of-function Trp53 mutants also co-operate with oncogenic Kras to induce LUADs with shortened latency and increased metastatic proclivity, although these tumors are less aggressive than those with Lkb1 loss69–71, 84.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [84]
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“Only point mutation or deletion 8 of 80 (10) 4 of 42 (10) 1 of 22 (5) 13 of 144 (9) Only single-copy loss by MLPA 11 of 80 (14) 2 of 42 (5) 1 of 22 (5) 14 of 144 (10) Homozygous mutation or deletion 8{ of 80 (10) 2 of 42 (5) 0 of 22 (0) 10 of 144 (7) Total 27 of 80 (34) 8 of 42 (19) 2 of 22 (9) 37 of 144 (26)”
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,887 · cited 1×
“Only point mutation or deletion 8 of 80 (10) 4 of 42 (10) 1 of 22 (5) 13 of 144 (9) Only single-copy loss by MLPA 11 of 80 (14) 2 of 42 (5) 1 of 22 (5) 14 of 144 (10) Homozygous mutation or deletion 8{ of 80 (10) 2 of 42 (5) 0 of 22 (0) 10 of 144 (7) Total 27 of 80 (34) 8 of 42 (19) 2 of 22 (9) 37 of 144 (26)”
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898 · cited 1×
“Only point mutation or deletion 8 of 80 (10) 4 of 42 (10) 1 of 22 (5) 13 of 144 (9) Only single-copy loss by MLPA 11 of 80 (14) 2 of 42 (5) 1 of 22 (5) 14 of 144 (10) Homozygous mutation or deletion 8{ of 80 (10) 2 of 42 (5) 0 of 22 (0) 10 of 144 (7) Total 27 of 80 (34) 8 of 42 (19) 2 of 22 (9) 37 of 144 (26)”
Self-citationRole of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Molecular Definition of Breast Tumor Heterogeneity
Shipitsin, M., Campbell, L. L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.013 · Cited by 1,353
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179 · cited 1×
“Only point mutation or deletion 8 of 80 (10) 4 of 42 (10) 1 of 22 (5) 13 of 144 (9) Only single-copy loss by MLPA 11 of 80 (14) 2 of 42 (5) 1 of 22 (5) 14 of 144 (10) Homozygous mutation or deletion 8{ of 80 (10) 2 of 42 (5) 0 of 22 (0) 10 of 144 (7) Total 27 of 80 (34) 8 of 42 (19) 2 of 22 (9) 37 of 144 (26)”
Self-citationThe LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,077
Self-citation
Cited by
Items 901–1,000 of 1,000
Therapy-induced cholesterol biosynthesis drives lung cancer dormancy and drug resistance
Zhao, Y., Zhou, Y., Pan, L., Tian, G. G., Huang, H., Tang, S., Lu, M., Zhou, Z., Zhang, P., Chen, L., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci191735 · Cited by 1
Self-citationMi, W., Xia, X., Xue, Y., Li, L., Yang, L., Yang, X., Xu, J., Cai, X., Zhou, Y., Zhu, L., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117487 · Cited by 1
Self-citationYan, P., Jiang, W., Xue, X., Hou, T., Wang, J., Huang, D., Chen, L., Inuzuka, H., Dai, X., & Wei, W. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218678 · Cited by 2
Self-citationLineage identity governs oncogene dependence in mouse NSCLC models of KRAS inhibitor resistance
Mathey‐Andrews, N., Rodriguez, C. L., Shui, B., Patriotis, A. L., Rideout, W. M., Chen, V. Z., Murazzi, I., Ghazi, P., Cornwall-Brady, M. R., Liu, M., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02768-8 · Cited by 2
“In Lkb1 -deficient models that underwent spontaneous adenosquamous transition 19,21,22 , Ji and colleagues identified Krt6a as a biomarker of this plasticity 19 .”
“Personalizing” Therapy for Non-Small Cell Lung Cancer
D’Cunha, J. (2010) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2010.08.005 · Cited by 1
Strewler, G. J. (2008) · IBMS BoneKEy · doi:10.1138/20080330 · Cited by 1
Popper, H. (2016) · Springer eBooks · doi:10.1007/978-3-662-50491-8_17 · Cited by 1
Genetically Engineered Mouse Models of Pancreatic Ductal Adenocarcinoma
Hezel, A. F., & Bardeesy, N. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-968-0_16 · Cited by 1
Self-citationArber, N., & Moshkowitz, M. (2012) · Wiley eBooks · doi:10.1002/9781118423318.ch4 · Cited by 1
Ignoring matrix boundaries when the LKB1 master kinase is gone
Danen, E. H. J. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201409107 · Cited by 1
“Moreover, evidence from mouse models points to a prominent role for LKB1 as a suppres sor of metastasis in lung cancer and melanoma (Ji et al., 2007; Liu et al., 2012).”
BackgroundN -methylnitrosourea aggravates gastrointestinal polyposis in Lkb1+/− mice
Udd, L., Gao, Y., Ristimaki, A. P., & Mäkelä, T. P. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt188 · Cited by 1
“Two potential candidates could be Ras collaborating with Lkb1 loss in skin (32) and lung (32,44) tumourigenesis, or Myc collaborating with Lkb1 in mammary gland tumourigenesis (45).”
BackgroundHwang, K., Jo, H.-J., Lee, K. K., Shim, H., Song, J. S., Shin, J., Shin, S. N., Park, S., Hong, K., Park, J., et al. (2008) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2008.64.5.362 · Cited by 1
miRNAs associated with the malignant transformation of non-small cell lung cancer
Wang, D., Zhang, Q., & Jin, Y. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw006 · Cited by 1
The epigenomic impact of methylation in metabolic dysfunction and cancer
Zahnow, C. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816843-1.00005-9 · Cited by 1
Muro‐Cacho, C. (2015) · John Wiley & Sons, Inc. eBooks · doi:10.1002/9781118834015.ch107 · Cited by 1
Najjary, S., Mustafa, D. A. M., & Kros, J. M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106385 · Cited by 1
Chevallier, A. (2012) · theses.fr (ABES) · doi:10.70675/1594f454zf8a8z4854z9465zab7b3214bb01 · Cited by 4
Genetic and Chemical Modifiers of EGFR Dependence in Non-Small Cell Lung Cancer
Sharifnia, T. (2014) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Mouse Models of Human Cancer: Role in Preclinical Testing and Personalized Medicine
Berger, A. H., & Pandolfi, P. P. (2011) · Springer eBooks · doi:10.1007/978-0-387-69805-2_27 · Cited by 1
Prognostic and Predictive Value of KRAS Mutation in NSCLC
Yamamoto, S., Washington, L., & Komiya, T. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.04.035 · Cited by 1
Ly, S. H. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 2
Lkb1 is a master regulator of VSMC fate and function in micePreprint
Cai, Z., Song, P., You, S., Liu, Z., Zhao, F., Mu, J., Zheng, X., Ding, Y., Xiao, L., Ramprasath, T., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.12.422410 · Cited by 1
“Liver kinase b1 (Lkb1), a tumor suppressor, is mutated and strongly implicated in Peutz– Jeghers syndrome, cervical carcinoma, and non-small-cell lung carcinomas (13-15).”
BackgroundYang, C. (2014) · Digital Commons-TMC (Texas Medical Center) · Cited by 1
Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesisPreprint
Seong, C.-S., Huang, C., Boese, A. C., Hou, Y., Koo, J., Mouw, J. K., Rupji, M., Joseph, G., Johnston, H. R., Claussen, H., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.26.525772 · Cited by 1
ERBB signalling contributes to immune evasion in KRAS-driven lung adenocarcinomaPreprint
Laing, S., Kruspig, B., Shaw, R., Officer-Jones, L., Edwards, S. C., McKinven, D., Hsieh, Y.-C., Powley, I. R., Brady, N., Pennie, R. L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.24.550274 · Cited by 1
“13 MATERIALS & METHODS Mice and In Vivo Procedures The LSL-KRAS (65), Rosa26 (30), Hprt-lsl-IRFP (66), Trp53 (67), Stk11 (28), and B6.”
BackgroundInfluentialA Lung Cancer Mouse Model DatabasePreprint
Cai, L., Gao, Y., DeBerardinis, R. J., Acquaah-Mensah, G. K., Aidinis, V., Beane, J., Biswal, S. S., Chen, T., Concepcion, C. P., Grüner, B. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.28.582577 · Cited by 1
Controlled Chaos: Parsing Acquired Immunoresistance in Lung Cancer
Henick, B. S., Herzberg, B. O., Concepcion, C. P., & Taylor, A. M. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02339 · Cited by 2
DCAS supports cell polarization and cell-cell adhesion complexes in development
Tikhmyanova, N., & Golemis, E. A. (2010) · iDEA - Drexel University Institutional Repository · doi:10.17918/00002060 · Cited by 1
LKB1 tumor suppression in Peutz-Jeghers Syndrome
Katajisto, P. (2008) · Työväentutkimus Vuosikirja · Cited by 1
Sarlak, S. (2021) · theses.fr (ABES) · doi:10.70675/2e2c5420z3a1fz49c3zb548z8e72b24a52b2 · Cited by 1
Identification and Function of Ets Target Genes Involved in Lung Cancer Progression
Kathuria, H. (2011) · Defense Technical Information Center (DTIC) · doi:10.21236/ada555912
Tumor Microenvironment, Angiogenesis Biology, and Targeted Therapy
Heymach, J. V., & Cascone, T. (2014) · Lung Cancer · doi:10.1002/9781118468791.ch33
Targeting Redox Homeostasis in LKB1-deficient NSCLC
Young, J. D., & Whang, Y. M. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada614534
Mecanismos de regulación de transportadores de membrana. Interacción entre AMPK y Nedd4.2
LORENTE, G. H. (2012) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/14577
Novel Posttranslational Modification in LKB1 Activation and Function
Lee, S.-W. (2014) · Digital Commons-TMC (Texas Medical Center)
Stromal Cells and Tumor Milieu: PDGF et al.
Jacob, M., & Puré, E. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0711-0_14
Mouse model resembling human lung cancer
Xiao, Z., Jiang, Q., Willette‐Brown, J., & Hu, Y. (2013) · Oncotarget · doi:10.18632/oncotarget.1017
Mighty mouse breakthroughs: a Sox2-driven model for squamous cell lung cancer
Mukhopadhyay, A., & Oliver, T. G. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.969651
“One of the first models generated involved homozygous inactivation of liver kinase B1 (Lkb1) in the context of Kirsten rat sarcoma viral oncogene homolog (Kras)-driven lung tumors.(4) This resulted in a mixed spectrum of lung tumor types, including squamous tumors.”
BackgroundLarsen, J. E., & Minna, J. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.044 · Cited by 1
Inflammation and Lung Cancer: Prevention
Bauer, A. K., Miller, Y. E., & Keith, R. L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2724-1_4
Vaahtomeri, K. (2011) · Helda - University of Helsinki Institutional Repository
Functional Genomics Based Interrogation of Cell-Fate Determination Pathways
Jacob, L. S. (2011)
The tumor suppressing roles of tissue structure in cervical cancer development
Nguyen, H. (2013) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1868
Prakasam, G., Singh, R. K., Iqbal, M. A., Tiku, A. B., & Bamezai, R. N. K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.729079
“Cell lines, MCF-7 (Human Breast Adenocarcinoma), MDA-MB-231 (Human Breast Adenocarcinoma), PC-3 (Human Prostate Adenocarcinoma), H1299 (Non-Small Cell Lung Carcinoma), A549 (Lung Carcinoma), HeLa 2 by guest on July 18, 2018 http://w w w .jbc.org/ D ow nloaded from (Human Cervical Adenocarcinoma), HEK293T (Human Embryo…”
MethodInfluentialRetractedInhibition of mTOR Pathway and Induction of Autophagy Block Lymphoma Cell Growth
Wang, L., & Wei-Li, Z. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405529-2.00020-2
Pathophysiologic Role of Autophagy in Human Airways
Sica, V., & Izzo, V. (2016) · Springer eBooks · doi:10.1007/978-3-319-30079-5_16
Lung Cancer Among Asian Americans
Park, S., Stram, D. O., Rouen, M. D., Gomez, S. L., Wu, A. H., & Cheng, I. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-41118-7_5
Pasko, E. (2015) · TSpace (University of Toronto)
Loss of LKB1 Leads to Alteration of the Immune Microenvironment in Non-Small Cell Lung Cancer
Friel, J. M. (2015) · Arizona State University Library Digital Repository (Arizona State University)
Regulation of the tumor suppressor LKB1 by the acetyltransferase GCN5
Ghawitian, M. (2015) · theses.fr (ABES) · doi:10.70675/eb6cdaacza9dbz4ff8z9b39z9b9381d1b77a
“In mice, both homo- and heterozygous loss of Lkb1, combined with Kras activation, promote lung carcinogenesis and metastasis (Ji et al., 2007).”
BackgroundUnderstanding the Regulation of HMGCR
Hassanabad, A. F. (2013) · Library and Archives Canada (Government of Canada) · Cited by 1
Zou, M., Okon, I. S., & Coughlan, K. A. (2014)
Investigação das quinases Aurora A e Aurora B na tumorigenicidade mediada pelo oncogene KRAS
dos Santos, E. O. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2017.tde-21062017-103949 · Cited by 1
Molecular mechanisms of kinase inhibitor resistance in melanoma
Cesi, G. (2017) · Open Repository and Bibliography (University of Luxembourg)
Underlying Mechanisms Of Arsenic-Induced Tumorigenesis: From Epigenetics To Malignancy
Li, L. (2017) · Human Biology · Cited by 1
The Neurodegenerative Drosophila Melanogaster Ampk Mutant Loechrig
Cook, M. (2012) · Online Publication Service of Würzburg University (Würzburg University)
Continuing the search for mutational drivers in esophageal adenocarcinoma
Samson, P. P. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.12.076
LKB1, gardien de la prolifération hépatocytaire et de l’intégrité génomique
Maillet, V. (2017) · theses.fr (ABES) · doi:10.70675/866ae571z2346z41d6zb476z517646b200a0
Novel metabolic regulations exerted by LKB1 signaling in polarized cells : impact on tissue ontogeny
Radu, A. G. (2018) · theses.fr (ABES) · doi:10.70675/4857176dz0993z4049z97c4zf8092fcf1e2e · Cited by 1
“Moreover, it has been observed that LKB1 regulates lung cancer initiation, differentiation and metastasis (Ji et al., 2007).”
BackgroundRussu, M. C., Nastasia, S. I., Degeratu, D., & Stănculescu, R. V. (2018) · InTech eBooks · doi:10.5772/intechopen.75044
“These abnormalities were first discovered in connection to Peutz-Jeghers Syndrome [63] and pulmonary cancer [64].”
BackgroundNagaraj, A. S. (2018) · Helda - University of Helsinki Institutional Repository · Cited by 1
Genome editing of LKB1 (STK11) mutation in A549 lung cancer cells using CRISPR/Cas9 system
Morelli, A. P., Simabuco, F. M., Pavan, I. C. B., Tavares, M. R., da Silva, L. G. S., Pereira, N. F. P., Silva, F. R., Tortelli, T. C., & Chammas, R. J. (2018) · Revista dos Trabalhos de Iniciação Científica da UNICAMP · doi:10.20396/revpibic262018138
LKB1, a Key Driver Gene of Human Lung Squamous Cell Carcinoma
Yu, Q. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.19.003302
Deciphering the cells of origin of squamous cell carcinomas
Sánchez‐Danés, A., & Blanpain, C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0025-9 · Cited by 1
Inactivation of JNK1/2 Promotes Lung Squamous Cell Carcinoma in Lkb1 Deficiency Mice
Song, J. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.20.003505
“Unlike previous Lung SCC (LSCC) models in which compound mutations and depletions were involved such as 12 / 1 G D loss Kras Lkb , 2 / 1 ox loss Sox Lkb , or / 1 loss loss Pten Lkb [5,7], Jian Liu et al.”
BackgroundInfluentialLinear regression for data having multicollinearity, heteroscedasticity and outliers
Rasheed, B. A. (2017)
Azam, S. H. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/jc8a-4746
Macaya, I., Entrialgo‐Cadierno, R., Valencia, K., & Vicent, S. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.11.017
“cell–derived xenografts and a genetically engineered mouse model of lung cancer driven by mutant Kras and Lkb1 deletions (Kras and Lkb1, respectively).(14) These current findings describing the exquisite sensitivity of LKB1-deficient cells to ERKis are in tune”
BackgroundRackley, B. B., Kiely, E. J., Seong, C.-S., Rupji, M., & Gilbert‐Ross, M. (2020) · PubMed Central · doi:10.17912/micropub.biology.000223
“Additionally, previous work from genetically engineered mouse models (GEMMs) suggests loss of Lkb1 is sufficient to promote the progression and metastasis of nascent Kras-driven lung adenocarcinoma (Ji et al. 2007).”
BackgroundBillaud, A. (2020) · theses.fr (ABES) · doi:10.70675/2e9e8fb9z32d6z43d2z9534zb1ac5dc9176a
Lkb1 controls expansion and folding of the cerebellar cortex
Ryan, K. E. (2014)
Hu, Y., Wu, M., Gu, N., Qiu, X.-S., Wang, E., & Wu, G. (2020) · doi:10.21203/rs.3.rs-19692/v1
“It had been shown that LKB1 is the key barrier of lung tumorigenesis, which controlled the occurrence, differentiation and metastasis of lung tumorigenesis [14].”
BackgroundSelf-citationChen, F. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.114
The conductors of the metabolic orchestra
Koltai, T., Reshkin, S. J., Baltazar, F., & Fliegel, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90528-2.00006-0
Genomics-based Precision Medicine for Patients with Cancer
van de Haar, J. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/946
Genetic Approaches to Study Transcriptional Activation and Tumor Suppression: A Dissertation
Lin, L. (2012) · eScholarship@UMassChan · doi:10.13028/q44r-af46
Regulation of the Mechanistic Target of Rapamycin by Cellular Stress.
Magnuson, B. (2013) · Deep Blue (University of Michigan)
(2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416570-0.00043-3
3’UTR-dependent dynamic changes in TP53 mRNA localization regulate p53 tumor suppressor activityPreprint
Hu, L., Misra, S., Karim, B. O., Kuhn, S. A., Salotti, J., Basu, S., Martín, N. C. R., Saylor, K. L., & Johnson, P. F. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.04.487038 · Cited by 1
Fry, A. M., & Lucken, K. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.740166309.793585867
Hu, Y., Wu, M., Gu, N., Qiu, X.-S., Wang, E., & Wu, G. (2020) · doi:10.21203/rs.3.rs-19692/v2
Self-citationVuori, K., & Zhao, M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736274644.793566082
Little, J. L., & Golemis, E. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6613-0_44-2
Little, J. L., & Golemis, E. A. (2017) · Springer eBooks · doi:10.1007/978-1-4419-0717-2_44
Vuori, K., & Zhao, M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737595225.793573384
Sage, J. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734933971.793556947
Modeling Resistance to Immune Checkpoint Blockade
Quigley, M. M., Meyer, M. J., & Katlinski, K. V. (2022) · Wiley eBooks · doi:10.1002/9781119535331.ch4
Development of an adenosquamous carcinoma histopathology – selective lung metastasis model
Lähdeniemi, I. A. K., Devlin, J. R., Nagaraj, A. S., Talwelkar, S. S., Bao, J., Linnavirta, N., Şeref, C., Kiss, E. A., Hemmes, A., & Verschuren, E. W. (2022) · Biology Open · doi:10.1242/bio.059623
“Kras LSL(G12D)/WT (C57BL/6J background) were bred with Lkb1 fl/fl (F4 ICR;BALB/cByJ;FVB/N background) to generate Kras LSL(G12D)/WT ;Lkb1 fl/fl (KL) strains (Ji et al., 2007).”
Ganesan, K., Ivanova, T. I., Wu, Y., Rajasegaran, V., Wu, J., Lee, M. H., Kun, Y., Rha, S. Y., Chung, H. C., Ylstra, B., et al. (2023) · doi:10.1158/0008-5472.c.6497583
Data from NEDD9 Promotes Oncogenic Signaling in Mammary Tumor Development
Izumchenko, E., Singh, M. K., Plotnikova, O. V., Tikhmyanova, N., Little, J. L., Serebriiskii, I. G., Seo, S., Kurokawa, M., Egleston, B. L., Klein–Szanto, A. J., et al. (2023) · doi:10.1158/0008-5472.c.6499181.v1
Koenig, M. J., Agana, B. A., Kaufman, J. M., Sharpnack, M. F., Wang, W., Weigel, C., Navarro, F. C. P., Amann, J. M., Cacciato, N., Arasada, R. R., et al. (2023) · doi:10.1158/0008-5472.c.6513136.v1
Data from Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer
Deneka, A. Y., Kopp, M. C., Nikonova, A. S., Gaponova, A. V., Kiseleva, A. A., Hensley, H. H., Flieder, D. B., Serebriiskii, I. G., & Golemis, E. A. (2023) · doi:10.1158/0008-5472.c.6512911.v1
Metadata
- Authors
- Ji, H., Ramsey, M. R., Hayes, D. N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M. C., Shimamura, T., Perera, S. A., Liang, M.-C., Cai, D., Naumov, G. N., Bao, L., Contreras, C. M., Li, D., Chen, L., Krishnamurthy, J., Koivunen, J., Chirieac, L. R., Padera, R. F., Bronson, R. T., Lindeman, N. I., Christiani, D. C., Lin, X., Shapiro, G. I., Jänne, P. A., Johnson, B. E., Meyerson, M., Kwiatkowski, D. J., Castrillon, D. H., Bardeesy, N., Sharpless, N. E., & Wong, K.-K.
- Affiliations
- Dana-Farber Cancer Institute (US)
- University of North Carolina at Chapel Hill (US)
- Harvard University (US)
- University of Tennessee Health Science Center (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Bardeesy, Nabeel
- Sharpless, Norman E.
- Wong, Kwok-Kin
- ORCID
- Ji, Hongbin
- Ramsey, Matthew R.
- Hayes, D. Neil
- Wu, Michael C.
- Shimamura, Takeshi
- Perera, Samanthi A.
- Liang, Mei-Chih
- Bao, Lei
- Chen, Liang
- Koivunen, Jussi
- Chirieac, Lucian R.
- Padera, Robert F.
- Bronson, Roderick T.
- Lindeman, Neal I.
- Christiani, David C.
- Lin, Xihong
- Shapiro, Geoffrey I.
- Johnson, Bruce E.
- Meyerson, Matthew
- Kwiatkowski, David J.
- Bardeesy, Nabeel
- Sharpless, Norman E.
- Wong, Kwok-Kin
- Venue
- Nature
- Published
- 2007-08-05
- Volume
- 448
- Issue
- 7155
- Pages
- 807-810
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2134964552
- Cited by
- 1,064
- References
- 36
- Citations by year
- 2026: 30 · 2025: 43 · 2024: 44 · 2023: 66 · 2022: 50 · 2021: 71 · 2020: 51 · 2019: 66 · 2018: 61 · 2017: 56 · 2016: 54 · 2015: 72 · 2014: 83 · 2013: 65 · 2012: 52
- FWCI
- 24.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- LKB1, STK11, lung cancer, tumour suppressor, metastasis, squamous cell carcinoma, non-small cell lung cancer, KRAS, p53, Ink4a/Arf, CDKN2A, tumor differentiation, Peutz-Jeghers syndrome, metastasis-promoting genes
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Animals, Carcinoma, Non-Small-Cell Lung, Cell Differentiation, Disease Models, Animal, Humans, Lung Neoplasms, Neoplasm Metastasis, Genes, ras, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, Genes, p53, Protein Serine-Threonine Kinases, Genes, p16, Gene Expression Profiling, Cell Line, Tumor, Mice, Genes, Neoplasm, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.